• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Kroger Health to Offer Smartphone-Enabled COVID-19 Tests Nationwide

Share:

February 24, 2021

Highlights on this story:
  • Kroger Health, the healthcare division of The Kroger Co. announced plans to offer the first smartphone-enabled, at-home Gauss COVID-19 Rapid Antigen Test Kit to patients nationwide, expanding the company’s existing portfolio of in-clinic and employer-focused COVID-19 testing solutions.
  • Kroger Health expects the at-home rapid antigen test will be available to purchase on Kroger.com and over the counter at its 2,200 pharmacies nationwide.

The test, developed by Gauss and Cellex, Inc., a biotechnology company specializing in rapid diagnostics, is powered by an encrypted, easy-to-use smartphone app developed by Gauss’s team of clinical and technology leaders. According to results of a clinical trial submitted to the FDA in support of the solutions EUA application, the testing solution demonstrated a 93% positive agreement and 99% negative percent agreement compared to high-sensitivity, emergency-use-authorized PCR tests.

Gauss At-Home COVID-19 Testing Solution

The new at-home testing solution, which is currently awaiting Food and Drug Administration (FDA) Emergency Use Authorization (EUA), will offer affordable access to cutting-edge testing technology developed by Gauss, a leader in computer vision-aided healthcare diagnostics. Once authorized, it will be the first rapid COVID-19 test that can be fully performed using only a smartphone and a lateral flow assay (similar to an at-home pregnancy test), without involving a laboratory, a telemedicine visit or any specialized electronics. Last month, Gauss produced its first 1.5 million tests, which will be available for immediate distribution when the test receives EUA from the FDA, and the company has the capability to produce up to 30 million tests per month.

How the Test Works

To use the test, patients follow simple step-by-step video instructions in an app to properly collect the nasal swab and complete the rapid antigen test. After 15 minutes, the app prompts the patient to scan their rapid test. The app uses patent-pending, artificial-intelligence-based technology to provide patients with their results in seconds, helping minimize reader variability. To fulfill legal reporting requirements, the consumer-friendly app seamlessly also shares the reliable, secure results with appropriate public health agencies.

“Since the start of the COVID-19 pandemic, Kroger Heath has remained committed to helping people live healthier lives by offering a variety of COVID-19 testing solutions supported by our multi-disciplinary team of licensed, trained and experienced healthcare providers,” said Colleen Lindholz, president of Kroger Health. “We’re proud to partner with Gauss to expand our COVIDCare+ suite with the forthcoming launch of this affordable, innovative solution.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: hit consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Designating Ownership of Provider Data Will Improve Care Coordination, Study FindsDesignating Ownership of Provider Data Will Improve Care Coordination, Study Finds
  • Health Catalyst Acquires Clinical Workflow Optimization Solution HealthfinchHealth Catalyst Acquires Clinical Workflow Optimization Solution Healthfinch
  • How the World of Health and Tech is Looking at the Coronavirus OutbreakHow the World of Health and Tech is Looking at the Coronavirus Outbreak
  • BioLife Solutions Acquires Custom Biogenic SystemsBioLife Solutions Acquires Custom Biogenic Systems
  • Global Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the CompanyGlobal Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the Company
  • OrthoPediatrics Corp. Completes Acquisition of Pega MedicalOrthoPediatrics Corp. Completes Acquisition of Pega Medical
  • Eko Unveils Algorithm to Assist in the Detection of Aortic Stenosis, a Valvular Heart Disease Affecting Over 3 Million People in the U.S.Eko Unveils Algorithm to Assist in the Detection of Aortic Stenosis, a Valvular Heart Disease Affecting Over 3 Million People in the U.S.
  • NTRON, Manufacturer of Gas-Measurement and Analysis Solutions, Joins Battery Ventures’ Process Sensing Technologies GroupNTRON, Manufacturer of Gas-Measurement and Analysis Solutions, Joins Battery Ventures’ Process Sensing Technologies Group

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications